Article
Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs.
Antimicrobial agents and chemotherapy - 1 Mar 2010
Binet Rachel, Bowlin Anne K, Maurelli Anthony T, Rank Roger G
Abstract excerpt
Azithromycin (AZM) is a major drug used in the treatment and prophylaxis of infections caused by Chlamydia, yet no significant clinical resistance has been reported for these obligate intracellular bacteria. Nevertheless, spontaneous AZM resistance (Azm(r)) arose in vitro at frequencies ranging f...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
